Please provide your email address to receive an email when new articles are posted on . A 78-year-old woman was referred to the neuro-ophthalmology service at New England Eye Center for several months ...

A 34-year-old woman was transferred to the University of New Mexico emergency department with a 3-day history of progressive left eye swelling. She complained of mild blurry vision, diplopia, ...

We observed 13 patients who developed a subsequent increase in exophthalmometry measurements in the non-proptotic eye within a period ranging from 6 months to 7 years. We believe that such a variable ...

Findings from THRIVE showed treatment with veligrotug led to statistically significant improvements in the signs and symptoms of TED. Topline data were announced from a phase 3 study evaluating ...

Credit: Getty Images. Tepezza is a human insulin-like growth factor-1 receptor inhibitor. Tepezza ® (teprotumumab-trbw) significantly reduced proptosis in adults with chronic thyroid eye disease (TED) ...

Dr. Mark A. Matza (Medicine): An 18-year-old man was evaluated at this hospital because of diplopia and proptosis of the left eye. The patient had been well until approximately 33 months before this ...

Q: Which doctor should I consult for Bulging Eyes? A: You may consult your family physician initially who may refer you to an ophthalmologist (eye doctor) or an endocrinologist (specialist who treats ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...

Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian Therapeutics announced positive long-term durability data from its Phase 3 ...

Of the 655 patients enrolled in this study, 89 (13.5%) (95% confidence interval [CI] 15%-10%) presented with unilateral exophthalmos. Exophthalmometer values in the ...